ストックスクリーナーアプリを入手
8.60
3.24%
0.27
プレマーケット:
8.58
-0.02
-0.23%
Xeris Biopharma Holdings Inc (XERS) 最新ニュース
Walleye Capital LLC Invests $4.84 Million in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Why Xeris Biopharma Holdings (XERS) Is Up 8.4% After Tightening 2026 Revenue Guidance And Advancing XP-8121 - Yahoo Finance
Xeris Biopharma Holdings (XERS) Posts Record Q2 Revenue, Is It Still A Bargain? - Yahoo Finance
XERS|Xeris Biopharma Holdings Inc|Price:8.322|Chg%:-0.168 - TradingKey
Mission Produce And Two Other Stocks Estimated To Be Trading Below Intrinsic Value - simplywall.st
Xeris Biopharma (NASDAQ:XERS) Insider Sells $42,500.00 in Stock - MarketBeat
Xeris Biopharma (XERS) insider Steven Pieper plans Rule 144 sale of 20,000 shares - Stock Titan
HC Wainwright Comments on Xeris Biopharma FY2026 Earnings - MarketBeat
Janus Henderson Group PLC Boosts Stock Holdings in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Renaissance Technologies LLC Cuts Stock Position in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Xeris Biopharma Holdings Inc (XERS) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
HC Wainwright Expects Weaker Earnings for Xeris Biopharma - MarketBeat
Xeris Biopharma Holdings, Inc. (XERS) options chain – Yahoo Finance - Yahoo Finance Singapore
Sei Investments Co. Has $3.36 Million Stake in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Xeris Biopharma (XERS) Stock Jumps On Record Revenue Despite Wider Losses - Sahm
Xeris Biopharma (NASDAQ:XERS) Downgraded to "Buy" Rating by Wall Street Zen - MarketBeat
Xeris Biopharma Q2 Earnings Call Highlights - MarketBeat
Xeris Biopharma Holdings Inc (XERS) Stock News Today - TradingKey
Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: A Lucrative 53% Upside Potential for Investors - DirectorsTalk Interviews
Xeris Biopharma (NASDAQ:XERS) Issues Earnings Results, Misses Expectations By $0.19 EPS - MarketBeat
Xeris Biopharma Holdings Inc (XERS) (Q2 2026) Earnings Call High - GuruFocus
XERS Looks 53.1% Overvalued on GF Value™ as Insider Selling Pers - GuruFocus
Xeris Biopharma Holdings, Inc. 2026: Revenue $92.1M, EPS ($0.18) — 10-Q Summary - TradingView
Xeris raises outlook despite posting $31.1 million loss - Crain's Chicago Business
Xeris Biopharma (NASDAQ:XERS) Shares Gap Down Following Weak Earnings - MarketBeat
Is Xeris Biopharma Holdings Inc (XERS) Still a Smart Investment? - GuruFocus
Xeris Biopharma Holdings, Inc. Provides Revenue Guidance for the Full Year 2026 - marketscreener.com
Earnings call transcript: Xeris Biopharma posts Q2 2026 revenue beat, EPS miss - Investing.com
Xeris Biopharma Holdings, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
(XERS) Xeris Biopharma Expects Full Year 2026 Revenue Range $385M$390M, vs. FactSet Est of $385.9M - marketscreener.com
Q2 2026 Xeris Biopharma Holdings Inc Earnings Call Transcript - GuruFocus
Xeris Biopharma: Q2 Earnings Snapshot - marketscreener.com
XERS: Q2 2026 revenue grew 34% year-over-year, driven by Recorlev, with improved margins and strong outlook - TradingView
Xeris Biopharma Reports Second Quarter 2026 Financial Results - Business Wire
Xeris Q2 FY26 net loss widens to $31.1 million; revenue rises 29% to $92.1 million - Bitget
Xeris Biopharma (XERS) Insider Beth Hecht Sells 16,666 Shares - GuruFocus
Xeris Biopharma (NASDAQ:XERS) Insider Kevin Mcculloch Sells 15,000 Shares of Stock - MarketBeat
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Vanguard Capital Management (XERS) discloses 8.64M-share, 5% holding in Xeris - Stock Titan
Xeris Biopharma Holdings (XERS) Stock Analysis: Promising 34% Upside Potential Amidst Robust Growth - DirectorsTalk Interviews
XERS Q2'26 Earnings: revenue estimate is 90.12M USD - TradingView
Rice Hall James & Associates LLC Acquires Shares of 251,066 Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Xeris Biopharma Holdings Inc (XERS) Cash Flow - TradingKey
Xeris Biopharma Holdings Inc (XERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Xeris Biopharma Holdings Inc (XERS) Income Statement - TradingKey
Xeris Biopharma Holdings Inc (XERS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Xeris Biopharma Holdings Inc (XERS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Xeris Biopharma Holdings Inc (XERS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
XERS|Xeris Biopharma Holdings Inc|Price:8.200|Chg%:-0.120 - TradingKey
Xeris Biopharma Holdings Inc (XERS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Xeris Biopharma Holdings, Inc. Revenue Breakdown – NASDAQ:XERS - TradingView
ETFs Investing in Xeris Biopharma Holdings, Inc. Stocks - TradingView
Xeris Biopharma Holdings, Inc. $XERS Shares Sold by Granahan Investment Management LLC - MarketBeat
Xeris Biopharma Holdings Inc (XERS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Xeris Biopharma Holdings Inc (XERS) Fundamental & Financial Data - Stocktwits
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 - BioSpace
Xeris Biopharma to report Q2 2026 results on Aug 6 - scanx.trade
Press Release: Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 - Moomoo
XERS5927663 Bond Coupon Profile — Rate & Payments - TradingView
XERS5927663 Bond Risk Profile - TradingView
XERS5927663 Bond Profile — Key Metrics - TradingView
Xeris Biopharma Holdings, Inc. Files Form 8-K With Key Company Details and NASDAQ Listing Information - Minichart
Xeris Biopharma Eliminates 2028 Convertible Notes Via Exchanges - TipRanks
Xeris Biopharma (Nasdaq: XERS) ends 8% 2028 notes via cash and stock - Stock Titan
Emerald Mutual Fund Advisers Trust Acquires New Shares in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat
Enterprise value to revenue forward of Xeris Biopharma Holdings, Inc. – NASDAQ:XERS - TradingView
Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last? - Yahoo Finance
0.79%
5.15%
大文字化:
|
ボリューム (24 時間):